PROVETOP

Biotinylated Human KIR3DL2 Protein

Catalog No: KIR3DL2-HB001

Species
Human
Expression System
HEK293
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Human KIR3DL2 Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Leu22-Leu339 (UniProt accession: P43630-1).

Product Details

Molecular Aliases
NKAT-4; NKAT4; CD158k; CL-5; KIR3DL2; NKAT4A; NKAT4B; p140; CL5
Protein Length
Leu22-Leu339
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 37.9 kDa. Due to glycosylation, the protein migrates to 35-45 kDa and 55-70 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Supplied as 0.22 μm filtered solution in PBS (pH 7.4).
State
Liquid
Storage Conditions
Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Data Display

Bis-Tris PAGE
KIR3DL2-HB001 Bis-Tris-PAGE-white result

Biotinylated Human KIR3DL2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

ELISA
KIR3DL2-HB001 ELISA result

Immobilized Biotinylated Human KIR3DL2, His Avi tag at 1μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml). Dose response curve for Anti-KIR3DL2 Antibody, hFc Tag with the EC50 of 16.1ng/ml determined by ELISA. (QC Test)

Background

KIR3DL2 is a member of the killer cell immunoglobulin-like receptor (KIR) family that was initially identified at the surface of natural killer (NK) cells. KIR3DL2, also known as CD158k, is expressed as a disulfide-linked homodimer. Each chain is composed of three immunoglobulin-like domains and a long cytoplasmic tail containing two immunoreceptor tyrosine-based inhibitory motifs.

References

  1. Schmitt C, Marie-Cardine A, Bensussan A. Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas. Front Immunol. 2017 Aug 30;8:1010. doi: 10.3389/fimmu.2017.01010. PMID: 28912774; PMCID: PMC5582066.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support